61 reports of this reaction
3.9% of all SELENIUM SULFIDE reports
#2 most reported adverse reaction
PRURITUS is the #2 most commonly reported adverse reaction for SELENIUM SULFIDE, manufactured by Chattem, Inc.. There are 61 FDA adverse event reports linking SELENIUM SULFIDE to PRURITUS. This represents approximately 3.9% of all 1,547 adverse event reports for this drug.
Patients taking SELENIUM SULFIDE who experience pruritus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRURITUS is moderately reported among SELENIUM SULFIDE users, representing a notable but not dominant share of adverse events.
In addition to pruritus, the following adverse reactions have been reported for SELENIUM SULFIDE:
The following drugs have also been linked to pruritus in FDA adverse event reports:
PRURITUS has been reported as an adverse event in 61 FDA reports for SELENIUM SULFIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRURITUS accounts for approximately 3.9% of all adverse event reports for SELENIUM SULFIDE, making it one of the most commonly reported side effect.
If you experience pruritus while taking SELENIUM SULFIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.